Citation 143982

GODA,Y: HOSHINO,K: AKIYAMA,H: ISHIKAWA,T: ABE,Y: NAKAMURA,T: OTSUKA,H: TAKEDA,Y: TANIMURA,A: TOYODA,M:. (1999). CONSTITUENTS IN WATERCRESS: INHIBITORS OF HSITAMINE RELEASE FROM RBL-2H3 CELLS INDUCED BY ANTIGEN STIMULATION.. 22(2)

Citation Details

Title	CONSTITUENTS IN WATERCRESS: INHIBITORS OF HSITAMINE RELEASE FROM RBL-2H3 CELLS INDUCED BY ANTIGEN STIMULATION.
Authors	GODA,Y: HOSHINO,K: AKIYAMA,H: ISHIKAWA,T: ABE,Y: NAKAMURA,T: OTSUKA,H: TAKEDA,Y: TANIMURA,A: TOYODA,M:
Year	1999
Volume	22
Issue	2

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN	ACTIVE

Nasturtium officinale (BRASSICACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	IONOL,BETA: 4-OXO: BETA-D-GLUCOPYRANOSIDE 9(R):	None
2	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IONOL,BETA: 4-OXO: BETA-D-GLUCOPYRANOSIDE 9(R):	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	IONOL,ALPHA: 3-OXO: BETA-D-GLUCOPYRANOSIDE (6R-9R):	None
4	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IONOL,ALPHA: 3-OXO: BETA-D-GLUCOPYRANOSIDE (6R-9R):	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FOR	IONOL,ALPHA: 6(S)-HYDROXY-3-OXO: 9(R)-O-BETA-D-GLUCOPYRANOSIDE	None
6	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	IONOL,ALPHA: 6(S)-HYDROXY-3-OXO: 9(R)-O-BETA-D-GLUCOPYRANOSIDE	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PHENETHYLAMINE	None
8	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENETHYLAMINE	INACTIVE
9	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ALANINE,PHENYL:	None
10	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALANINE,PHENYL:	INACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	QUERCETIN-3-SOPHOROSIDE-7-GLUCOSIDE	None
12	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-SOPHOROSIDE-7-GLUCOSIDE	ACTIVE
13	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	CARBOLINE,BETA: 1-2-3-4-TETRAHYDRO: 1-CARBOXYLIC ACID	None
14	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBOLINE,BETA: 1-2-3-4-TETRAHYDRO: 1-CARBOXYLIC ACID	INACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CARBOLINE,BETA: 1-2-3-4-TETRAHYDRO: 1-METHYL: 1-CARBOXYLIC ACID	None
16	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBOLINE,BETA: 1-2-3-4-TETRAHYDRO: 1-METHYL: 1-CARBOXYLIC ACID	INACTIVE
17	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RHAMNETIN-3-SOPHOROSIDE	None
18	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN-3-SOPHOROSIDE	ACTIVE
19	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RHAMNAZIN-3-SOPHOROSIDE	None
20	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNAZIN-3-SOPHOROSIDE	INACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RHAMNAZIN-3-GLUCOSIDE	None
22	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNAZIN-3-GLUCOSIDE	ACTIVE
23	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	RHAMNETIN-3-GLUCOSIDE	None
24	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN-3-GLUCOSIDE	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	ASTRAGALIN	None
26	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
27	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDQUANTITATIVE DATA	RHAMNETIN,ISO: 3-GLUCOSIDE	None
28	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNETIN,ISO: 3-GLUCOSIDE	ACTIVE
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RHAMNAZIN	None
30	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RHAMNAZIN	ACTIVE
31	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCITRIN,ISO:	None
32	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	ACTIVE